Indonesia’s Ministry of Health listed Micromeet in the Regulatory Sandbox category in its 2025–2026 Health Sandbox results. The programme results describe recommendations for Tanda Daftar ITK; the result must be read in the context of the scope assessed.
The Ministry’s results page is the starting point for understanding the programme result. A recommendation must be read alongside the scope assessed and any applicable follow-up. It should not be treated as a blanket finding for every product, feature, clinical outcome or deployment.
What a sandbox result can tell readers
The sandbox brings assessment and feedback into a structured process. The public programme result identifies the participating innovations and the programme outcome. When considering a particular solution, readers still need the relevant assessment scope and supporting evidence.
A recommendation for registration is a programme outcome. It should not be described as a medical device marketing authorisation or a data-security certification. The requirements that apply to a particular product or service depend on its intended use and the relevant rules.
Keep evidence and follow-up connected
A healthcare team evaluating AI needs to understand the intended task, the source information used and the clinical review point. It also needs to know what the available evidence covers and what remains open. A programme milestone does not establish performance for every institution or remove the need for local assessment.
Where follow-up is required, the organisation should identify the item, the responsible parties and the evidence needed to assess completion. A requirement for improvement does not, by itself, show that the improvement is complete. The public programme page is not evidence of a specific participant’s implementation status.
From a medical check-up to the next step
A medical check-up produces findings that need context. Clinical teams bring information together, explain its meaning and discuss the next step with the person receiving care. A recommendation for follow-up might involve another consultation, a test or a referral, depending on the clinician’s assessment.
The MCU reporting article discusses preparation of source information and clinical review. A separate article on MCU results for companies considers the different purposes of individual and employer-facing information.
What meaningful review needs
For an output that can affect clinical care, the authorised reviewer needs relevant source information, enough time to assess it, and the authority to correct or escalate it. The article on human review explains these conditions and why review should fit the consequences of the output.
A team considering a specific implementation should check whether those arrangements work in its own workflow. A programme result alone cannot show that they are present in every deployment.
Questions to bring to an evaluation
Before treating a programme result as relevant to a proposed workflow, clarify the intended task and population. Identify the evidence available for that specific use, the points where a person reviews the output, and the boundaries for handling information.
If a system will be connected to existing services, the institution should also assess the proposed connection and access permissions in its own environment. Those questions require evidence for the actual implementation rather than an assumption drawn from the sandbox result.
Frequently asked questions
What did the public programme results report?
The Ministry listed Micromeet in the Regulatory Sandbox category and described recommendations for Tanda Daftar ITK in its 2025–2026 programme results. Readers should check the programme source for its wording and context.
Does a recommendation establish performance for every use?
No. Assessments have a defined scope. Evidence for one evaluated use should not be extended automatically to every product, clinical claim or institution.
Does a follow-up requirement prove the work is complete?
No. A requirement describes work to be addressed. Completion needs separate, relevant evidence.
Discuss the workflow
Healthcare teams can use the reporting and information-sharing questions above to frame a discussion with their institution and service providers. The appropriate review depends on the workflow and evidence available.
Readers can also consult the official Health Sandbox innovation directory for programme context.
At Micromeet, clinical judgment stays with clinicians; the AI does not diagnose or sign. Institutions need to verify the capabilities and clinical review arrangements for each proposed implementation.
